Multiple Viral Infections and Antimicrobial Use in Hospitalized Children with Respiratory Illness During Pandemic and Early Post-pandemic Era, Taiwan

Overview

Journal Heliyon

Specialty Social Sciences

Date 2025 Feb 25

PMID 39995910

Authors

Chyi-Liang Chen

Yi-Ching Chen

Hsuan-Ling Hsiao

Yi-Jung Chang

Hsin-Chieh Li

Merve Arslan Aydin

Cheng-Hsun Chiu

Affiliations

Soon will be listed here.

Abstract

Background: Respiratory viral infections significantly burden pediatric populations. These infections are especially concerning in hospitalized children. Co-infection with bacteria may contribute to severe disease in children with respiratory viral infections.

Methods: The trend of children's respiratory infections during and after the pandemic was analyzed. FilmArray RP was used for etiology surveys of hospitalized children with acute respiratory illness in a medical center in northern Taiwan from October 2022 to March 2023. Antimicrobial days of therapy (DOT) were used to measure and compare the antimicrobial consumption between FilmArray RP test-positive and -negative groups. We also reviewed Taiwan CDC's surveillance data in the study period.

Results: Among 418 children tested, 271 cases showed positive results; 48.8 % (204/418) had a single virus identified. Multiple viruses were co-circulating in the community starting in September 2022. An increase in the number of influenza cases with severe complications in Taiwan was observed after October 2022. Following these viral infections, cases of invasive pneumococcal disease (IPD) began to increase from September 2022 onward. The FilmArray RP test results did not influence physicians' antibiotic prescribing, as there was no difference in DOT between the test-positive (single, double, or triple viruses-positive) and test-negative groups. However, the average DOTs in both groups were less than 10.

Conclusions: Multiple viruses were co-circulating in the community after the pandemic likely due to immune debt. Pediatric physicians continued to use antibiotics for febrile symptoms in hospitalized children with respiratory illness, even when viral pathogens were identified.

References

Agha R, Avner J . Delayed Seasonal RSV Surge Observed During the COVID-19 Pandemic. Pediatrics. 2021; 148(3). DOI: 10.1542/peds.2021-052089. View

Wolf D, Greenberg D, Shemer-Avni Y, Givon-Lavi N, Bar-Ziv J, Dagan R . Association of human metapneumovirus with radiologically diagnosed community-acquired alveolar pneumonia in young children. J Pediatr. 2009; 156(1):115-20. PMC: 7126976. DOI: 10.1016/j.jpeds.2009.07.014. View

Li Y, Wang X, Blau D, Caballero M, Feikin D, Gill C . Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 2022; 399(10340):2047-2064. PMC: 7613574. DOI: 10.1016/S0140-6736(22)00478-0. View

Casalegno J, Ploin D, Cantais A, Masson E, Bard E, Valette M . Characteristics of the delayed respiratory syncytial virus epidemic, 2020/2021, Rhône Loire, France. Euro Surveill. 2021; 26(29). PMC: 8299747. DOI: 10.2807/1560-7917.ES.2021.26.29.2100630. View

Weinberg G, Hall C, Iwane M, Poehling K, Edwards K, Griffin M . Parainfluenza virus infection of young children: estimates of the population-based burden of hospitalization. J Pediatr. 2009; 154(5):694-9. DOI: 10.1016/j.jpeds.2008.11.034. View

Ricketson L, Kellner J . Changes in the Incidence of Invasive Pneumococcal Disease in Calgary, Canada, during the SARS-CoV-2 Pandemic 2020-2022. Microorganisms. 2023; 11(5). PMC: 10222282. DOI: 10.3390/microorganisms11051333. View

Foley D, Yeoh D, Minney-Smith C, Martin A, Mace A, Sikazwe C . The Interseasonal Resurgence of Respiratory Syncytial Virus in Australian Children Following the Reduction of Coronavirus Disease 2019-Related Public Health Measures. Clin Infect Dis. 2021; 73(9):e2829-e2830. PMC: 7929151. DOI: 10.1093/cid/ciaa1906. View

Bertran M, Amin-Chowdhury Z, Sheppard C, Eletu S, Zamarreno D, Ramsay M . Increased Incidence of Invasive Pneumococcal Disease among Children after COVID-19 Pandemic, England. Emerg Infect Dis. 2022; 28(8):1669-1672. PMC: 9328924. DOI: 10.3201/eid2808.220304. View

Tiew W, Chen Y, Hsiao H, Chen C, Chen C, Chiu C . Impact of multiplex polymerase chain reaction syndromic panel on antibiotic use among hospitalized children with respiratory tract illness during COVID-19 pandemic. J Microbiol Immunol Infect. 2023; 56(4):688-694. PMC: 9841733. DOI: 10.1016/j.jmii.2023.01.009. View

10.

Delestrain C, Danis K, Hau I, Behillil S, Billard M, Krajten L . Impact of COVID-19 social distancing on viral infection in France: A delayed outbreak of RSV. Pediatr Pulmonol. 2021; 56(12):3669-3673. PMC: 8662089. DOI: 10.1002/ppul.25644. View

11.

Teoh Z, Conrey S, McNeal M, Burrell A, Burke R, Mattison C . Burden of Respiratory Viruses in Children Less Than 2 Years Old in a Community-based Longitudinal US Birth Cohort. Clin Infect Dis. 2023; 77(6):901-909. PMC: 10838707. DOI: 10.1093/cid/ciad289. View

12.

Janapatla R, Chen C, Dudek A, Li H, Yang H, Su L . Serotype transmission dynamics and reduced incidence of invasive pneumococcal disease caused by different serotypes after implementation of non-pharmaceutical interventions during COVID-19 pandemic. Eur Respir J. 2021; 58(5). PMC: 8311280. DOI: 10.1183/13993003.00978-2021. View

13.

Iannarella R, Lattanzi C, Cannata G, Argentiero A, Neglia C, Fainardi V . Coronavirus infections in children: from SARS and MERS to COVID-19, a narrative review of epidemiological and clinical features. Acta Biomed. 2020; 91(3):e2020032. PMC: 7716978. DOI: 10.23750/abm.v91i3.10294. View

14.

van Summeren J, Meijer A, Aspelund G, Casalegno J, Erna G, Hoang U . Low levels of respiratory syncytial virus activity in Europe during the 2020/21 season: what can we expect in the coming summer and autumn/winter?. Euro Surveill. 2021; 26(29). PMC: 8299745. DOI: 10.2807/1560-7917.ES.2021.26.29.2100639. View

15.

Hall C, Weinberg G, Blumkin A, Edwards K, Staat M, Schultz A . Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age. Pediatrics. 2013; 132(2):e341-8. DOI: 10.1542/peds.2013-0303. View

16.

Weinberger D, Grant L, Steiner C, Weatherholtz R, Santosham M, Viboud C . Seasonal drivers of pneumococcal disease incidence: impact of bacterial carriage and viral activity. Clin Infect Dis. 2013; 58(2):188-94. PMC: 3871795. DOI: 10.1093/cid/cit721. View

17.

Farahmand M, Shatizadeh Malekshahi S, Jabbari M, Shayestehpour M . The landscape of extrapulmonary manifestations of human parainfluenza viruses: A systematic narrative review. Microbiol Immunol. 2020; 65(1):1-9. DOI: 10.1111/1348-0421.12865. View

18.

Poehling K, Edwards K, Griffin M, Szilagyi P, Staat M, Iwane M . The burden of influenza in young children, 2004-2009. Pediatrics. 2013; 131(2):207-16. PMC: 3557405. DOI: 10.1542/peds.2012-1255. View

19.

Wolf R, Antoon J . Influenza in Children and Adolescents: Epidemiology, Management, and Prevention. Pediatr Rev. 2023; 44(11):605-617. PMC: 10676733. DOI: 10.1542/pir.2023-005962. View

20.

Britton P, Hu N, Saravanos G, Shrapnel J, Davis J, Snelling T . COVID-19 public health measures and respiratory syncytial virus. Lancet Child Adolesc Health. 2020; 4(11):e42-e43. PMC: 7500894. DOI: 10.1016/S2352-4642(20)30307-2. View